相关实验视频
Updated: May 28, 2026

08:54
Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
过氧化可诱导的DNA交联剂:向的抗癌前药物
Yunyan Kuang1, Kumudha Balakrishnan, Varsha Gandhi
1Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, 3210 North Cramer Street, Milwaukee, Wisconsin 53211, USA.
Journal of the American Chemical Society
|November 1, 2011
概括
研究人员开发了新型的末产药,通过癌细胞中的活性氧物种 (ROS) 激活. 这些ROS激活的抗癌剂对癌细胞具有很高的疗效,对正常细胞的毒性最小.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 抗癌化疗剂往往会导致严重的宿主毒性.
- 准独特的癌细胞生物化学提供了选择性癌症治疗的策略.
- 为癌症特异激活而设计的前体药物可以提高治疗效果并减少副作用.
研究的目的:
- 设计和合成新型酸末前制药.
- 通过高水平的活性氧物种 (ROS) 来实现癌细胞特异性激活.
- 评估这些ROS激活前药物的活性和选择性.
主要方法:
- 新型酸盐末产药的合成.
- 使用核磁共振 (NMR) 分析阐明激活机制.
- 评估DNA跨链交叉链和/或DNA基化以确定活性和选择性.
- 在体外对各种癌细胞系和正常淋巴细胞进行测试.
主要成果:
- 成功设计和合成了新型ROS激活末产药.
- 通过NMR分析证实了激活机制.
- 显示出显著的抗癌活性,60-90%抑制各种癌细胞.
- 显示高选择性,没有观察到对正常淋巴细胞的毒性.
结论:
- 这项研究提供了氧化 (H2O2) 激活的抗癌前期药物的第一个例子.
- 开发的前期药物为向癌症化疗提供了有希望的战略,并降低了宿主毒性.
- 由ROS激活的前期药物代表了选择性癌症治疗的新方法.
相关概念视频
Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
DNA Topoisomerases
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...

